8-（溴甲基）-5-氟喹啉

8-(bromomethyl)-5-fluoroquinoline

羟铝基氯化物, Al2O3：46%

ALUMINUM CHLOROHYDRATE

3-溴-2-甲基-6-硝基-2H-吲唑

3-bromo-2-methyl-6-nitro-2H-indazole

98%

cFMS受体抑制剂IV

cFMS Receptor Inhibitor IV

≥99%

[S(R)]-N-[(R)-(3,5-二(三氟甲基)苯基)[2-(二金刚烷基膦)苯基]甲基]-N-甲基-2-叔丁基亚磺酰胺

[S(R)]-N-[(R)-3,5-Bis(trifluoromethyl)phenyl)[2-(Diadamantanphosphino)phenyl]methyl]-N,2-dimethyl-2-propanesulfinamide

≥98%

4,4-二甲基氮杂环丁烷-2-酮, 98%

4,4-Dimethylazetidin-2-one

(3-((3-(三氟甲基)苯基)氨基甲酰)苯基)硼酸, 99%

(3-((3-(Trifluoromethyl)phenyl)carbamoyl)phenyl)boronic acid

2-((2,4-二溴苯氧基)甲基)四氢-2H-吡喃

2-((2,4-Dibromophenoxy)methyl)tetrahydro-2H-pyran

96%

4-(1H-苯并[d]咪唑-2-基)丁-2-酮, 98%

4-(1H-Benzo[d]imidazol-2-yl)butan-2-one

DMNPE笼式荧光素

DMNPE-caged Luciferin

≥98%

4-(6-甲基吡啶-2-基)吗啉, 98%

4-(6-Methylpyridin-2-yl)morpholine

GSK046

GSK046

99.9%

（E，Z）-1-溴-1,2-二苯基-2-（4-羟苯基）乙烯

(E,Z)-1-Bromo-1,2-diphenyl-2-(4-hydroxyphenyl)ethene

Methacrylate PEG, mPEG-MAR

Methacrylate PEG, mPEG-MAR

98%, MW 1000 Da

1-(2-甲氧乙基)-1-甲基吡咯烷鎓双(氟磺酰基)亚胺, ≥99%

1-(2-Methoxyethyl)-1-methylpyrrolidinium Bis(fluorosulfonyl)imide

1-（1H-1,3-苯并二唑-2-基）-2-甲基丁-1-胺盐酸盐

1-(1H-1,3-benzodiazol-2-yl)-2-methylbutan-1-amine dihydrochloride

4-咪唑基苯甲酰肼, ≥98%

Benzoic acid, 4-(1H-imidazol-1-yl)-, hydrazide

溴化钾, SP

Potassium bromide

N- [2-（3-乙酰基苯基）-2,3-二氢-异吲哚-1-基] -2-氯-乙酰胺

N-[2-(3-Acetyl-phenyl)-2,3-dihydro-isoindol-1-ylidene]-2-chloro-acetamide

4-氯-2-甲氧基苄醇, 98%

4-Chloro-2-Methoxybenzyl alcohol